Elaine S. E. Stokes

2.1k total citations · 1 hit paper
28 papers, 1.7k citations indexed

About

Elaine S. E. Stokes is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Elaine S. E. Stokes has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Immunology. Recurrent topics in Elaine S. E. Stokes's work include Protein purification and stability (8 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and Biosimilars and Bioanalytical Methods (5 papers). Elaine S. E. Stokes is often cited by papers focused on Protein purification and stability (8 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and Biosimilars and Bioanalytical Methods (5 papers). Elaine S. E. Stokes collaborates with scholars based in United Kingdom, United States and Denmark. Elaine S. E. Stokes's co-authors include Stephen R. Wedge, Jon Curwen, Laurent Hennequin, Jane Kendrew, Donald Ogilvie, Andrew P. Thomas, Michael Dukes, P.F. Wadsworth, Brenda J Curry and Patrick A. Plé and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer Research and Diabetes.

In The Last Decade

Elaine S. E. Stokes

28 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.

2002 702 citations Stephen R. Wedge, Donald Ogilvie et al. PubMed profile →

Peers

Countries citing papers authored by Elaine S. E. Stokes

Since Specialization

Citations

This map shows the geographic impact of Elaine S. E. Stokes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine S. E. Stokes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine S. E. Stokes more than expected).

Fields of papers citing papers by Elaine S. E. Stokes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine S. E. Stokes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine S. E. Stokes. The network helps show where Elaine S. E. Stokes may publish in the future.

Co-authorship network of co-authors of Elaine S. E. Stokes

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine S. E. Stokes. A scholar is included among the top collaborators of Elaine S. E. Stokes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine S. E. Stokes. Elaine S. E. Stokes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Industry Perspective Approach and Control Strategy for Implementation of Ready-to-Use Cells in Bioassays: Survey Outcome And Recommendations 2024 ·BioTechniques ·John R. White, (unknown), Jan Amstrup, (unknown), Zhi-jie Jey Cheng, Peter Day, (unknown), (unknown), (unknown), (unknown), Isam Qahwash, Elaine S. E. Stokes, (unknown)	1
2	An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals 2023 ·Journal of Pharmaceutical Sciences ·John M. Campbell, Stefano Colombo, (unknown), (unknown), (unknown), Laurent Magnenat, Ann K. Nowinski, (unknown), Surinder M. Singh, (unknown), (unknown), Elaine S. E. Stokes	6
3	An Intercompany Perspective on Practical Experiences of Predicting, Optimizing and Analyzing High Concentration Biologic Therapeutic Formulations 2022 ·Journal of Pharmaceutical Sciences ·(unknown), Patrick Garidel, (unknown), (unknown), (unknown), Chakravarthy Narasimhan, Shubhadra N. Singh, Elaine S. E. Stokes, (unknown)	6
4	An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug Products 2021 ·Journal of Pharmaceutical Sciences ·(unknown), George Crotts, Chakravarthy Narasimhan, Qingyan Hu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shubhadra N. Singh, (unknown), Yongmei Wu, Elaine S. E. Stokes	16
5	An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics 2020 ·Journal of Pharmaceutical Sciences ·Ahmed Besheer, (unknown), (unknown), (unknown), Pierre Goldbach, Qingyan Hu, (unknown), (unknown), Chakravarthy Narasimhan, Shubhadra N. Singh, Elaine S. E. Stokes, (unknown), (unknown), (unknown)	20
6	An Industry Perspective on Forced Degradation Studies of Biopharmaceuticals: Survey Outcome and Recommendations 2019 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), (unknown), Min Huang, Vikas Sharma, (unknown), Santosh V. Thakkar, (unknown), Wasfi Al‐Azzam, (unknown), Magdalena Gauden, Zhenyu Gu, Sambit R. Kar, Alexandru C. Lazar, (unknown), John J. Smith, Zoran Sosic, (unknown), Elaine S. E. Stokes	47
7	Best Practices in Bioassay Development to Support Registration of Biopharmaceuticals 2019 ·BioTechniques ·John R. White, Marla Abodeely, (unknown), (unknown), Evan Johnson, Debra M. Meyer, Ned M. Mozier, (unknown), (unknown), Isam Qahwash, Edward Rocnik, Jeffrey G. Smith, Elaine S. E. Stokes, (unknown), Pin Yee Wong	23
8	An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies 2017 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), George Crotts, Christine Wurth, (unknown), (unknown), Valentyn Antochshuk, Willow R. DiLuzio, Daniel Dix, (unknown), Kapil Gupta, Michael S. Fleming, Bing He, James K. Kranz, Dingjiang Liu, Chakravarthy Narasimhan, Eric Routhier, (unknown), (unknown), Elaine S. E. Stokes	4
9	The stereochemical course of bromoetherification of enynes 2008 ·Chemical Communications ·D. Christopher Braddock, (unknown), Yolanda Pérez-Fuertes, Rebecca H. Pouwer, Craig Roberts, (unknown), Elaine S. E. Stokes, Andrew J. P. White	23
10	Design and campaign synthesis of pyridine-based histone deacetylase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·David Andrews, (unknown), M. A. Graham, (unknown), Craig Roberts, Elaine S. E. Stokes, Madeleine C. Brady, Christine M. Chresta	6
11	Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·David Andrews, Elaine S. E. Stokes, (unknown), (unknown), Craig Roberts, Michael J. Waring, Madeleine C. Brady, Christine M. Chresta, (unknown)	11
12	A Biosynthetically-Inspired Synthesis of the Tetrahydrofuran Core of Obtusallenes II and IV 2006 ·Organic Letters ·D. Christopher Braddock, (unknown), David S. Millan, Yolanda Pérez-Fuertes, Craig Roberts, Richard N. Sheppard, (unknown), Elaine S. E. Stokes, Andrew J. P. White	30
13	The VEGF receptor tyrosine kinase inhibitor AZD2171 inhibits VEGF signaling, angiogenesis, and tumor growth in vivo 2004 ·Cancer Research ·Stephen R. Wedge, Jane Kendrew, (unknown), (unknown), Jon Curwen, Helen Musgrove, Martine J. Mellor, Sharon Barnett, P.F. Wadsworth, Graham H.P. Richmond, Alison Bigley, Laurent Hennequin, Patrick A. Plé, Elaine S. E. Stokes, Donald Ogilvie	7
14	Novel 4-Anilinoquinazolines with C-7 Basic Side Chains: Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors 2002 ·Journal of Medicinal Chemistry ·Laurent Hennequin, Elaine S. E. Stokes, Andrew P. Thomas, Craig Johnstone, Patrick A. Plé, Donald Ogilvie, Michael Dukes, Stephen R. Wedge, Jane Kendrew, Jon Curwen	254
15	A Novel Series of 4-Piperidinopyridine and 4-Piperidinopyrimidine Inhibitors of 2,3-Oxidosqualene Cyclase−Lanosterol Synthase 2000 ·Journal of Medicinal Chemistry ·George R. Brown, David M. Hollinshead, Elaine S. E. Stokes, David Waterson, David S. Clarke, Alan J. Foubister, (unknown), Fergus McTaggart, Donald J. Mirrlees, Graham J. Smith, Robin Wood	16
16	ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy. 2000 ·PubMed ·Stephen R. Wedge, (unknown), Michael Dukes, Jane Kendrew, Jon Curwen, Laurent Hennequin, (unknown), Elaine S. E. Stokes, Brenda J Curry, (unknown), P.F. Wadsworth	157
17	Quinuclidine Inhibitors of 2,3-Oxidosqualene Cyclase-Lanosterol Synthase: Optimization from Lipid Profiles 1999 ·Journal of Medicinal Chemistry ·George R. Brown, David M. Hollinshead, Elaine S. E. Stokes, David S. Clarke, M. Allan Eakin, Alan J. Foubister, (unknown), David E. Griffiths, Michael C. Johnson, Fergus McTaggart, Donald J. Mirrlees, Graham J. Smith, Robin Wood	16
18	Insulinoma Resection Facilitated by the Artificial Endocrine Pancreas 1978 ·Diabetes ·Jeffrey E. Kudlow, A. M. Albisser, Aubie Angel, Bernard Langer, Cecil C. Yip, Bernard Zinman, Elaine S. E. Stokes	21
19	The Metabolic Response to Moderate Exercise in Diabetic Man Receiving Intravenous and Subcutaneous Insulin 1977 ·The Journal of Clinical Endocrinology & Metabolism ·Frederick T. Murray, Bernard Zinman, Patricia McClean, (unknown), A. M. Albisser, B. S. Leibel, A. F. Nakhooda, Elaine S. E. Stokes, Errol B. Marliss	33
20	Cell Wall Growth in Bacillus licheniformis Followed by Immunofluorescence with Mucopeptide-Specific Antiserum 1971 ·Journal of Bacteriology ·R. Colin Hughes, Elaine S. E. Stokes	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact